Mirtazapine Tablet, Film Coated
Product Images NDC 71335-2412

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71335-2412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352412)

Label (Lbl713352412)
Mirtazapine Tablets, USP 7.5 mg film-coated tablets packaging label showing a 30-tablet count. The label includes storage instructions, a pharmacist note, and identifies Bryant Ranch Prepack as the repackager and Aurobindo Pharma Limited as the manufacturer. The NDC is 71335-2412-1.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure of mirtazapine, a human prescription drug active ingredient. The structure displays the arrangement of atoms and bonds characteristic of mirtazapine, consistent with its pharmaceutical identity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.